5 Nahum Het Street
MeMed is dedicated to improving patient lives through research, development, and commercialization of pioneering products that decode the immune system's distinct responses to different health and disease states. The company's most advanced product, ImmunoXpert™, accurately detects whether a patient has a bacterial or viral infection, with the aim of empowering physicians to make better informed antibiotic treatment decisions. ImmunoXpert™ is CE marked and approved for clinical use in the EU, Switzerland, and Israel.
Founder and CEO: Eran Eden, PhD
Founder and CTO: Kfir Oved, PhD, MD
CCO: Patrick F. Terry
Please click here for MeMed job opportunities.